Hisamitsu Pharmaceutical co.,inc.

News Release lR Information

2025.10.09

FY02/2026 Q2 Results Earnings Release Presentation
News Release lR Information

2025.10.03

Notice Regarding Status of Acquisition of Treasury Shares
News Release Sustainability

2025.10.01

Accelerating Carbon Neutrality through Renewable Energy Deployment
News Release lR Information

2025.09.03

Notice Regarding Status of Acquisition of Treasury Shares
News Release lR Information

2025.08.05

Notice Regarding Status of Acquisition of Treasury Shares

News Release lR Information

2025.10.09

FY02/2026 Q2 Results Earnings Release Presentation
News Release lR Information

2025.10.03

Notice Regarding Status of Acquisition of Treasury Shares
News Release Sustainability

2025.10.01

Accelerating Carbon Neutrality through Renewable Energy Deployment
News Release lR Information

2025.09.03

Notice Regarding Status of Acquisition of Treasury Shares
News Release lR Information

2025.08.05

Notice Regarding Status of Acquisition of Treasury Shares

More

Notice

2021.09.07

Notice regarding the outbreak status of COVID-19 infection
Notice

2021.08.18

Notification Regarding Honorary Chairman, Hisamitsu Pharmaceutical Co., Inc. Passes Away
Notice

2021.05.06

Measures to Prevent the Spread of COVID-19 at the 119th Annual General Meeting of Shareholders
Notice

2020.11.09

Notification of Voluntary Recall for Overseas Pharmaceutical Drug “SALONPAS_®” (2 Patches)
Notice

2020.07.03

Notification of Voluntary Recall for Topical Analgesic Patch “SALONPAS HOT_®” (Category 3 OTC Drug in Japan)

More